Bausch Health News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.04.22	Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation (PR Newswire)
28.04.22	Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting (PR Newswire)
27.04.22	Ortho Dermatologics Will Present Data at the 2022 Florida Society of Dermatology Physician Assistants New Wave Dermatology Conference (PR Newswire)
25.04.22	Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting (PR Newswire)
21.04.22	Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs (PR Newswire)
20.04.22	Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch Health (PR Newswire)
18.04.22	Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting (PR Newswire)
04.04.22	HALF OF IBS PATIENTS SURVEYED REPORT IBS SYMPTOMS MORE CHALLENGING TO MANAGE IN THE PAST YEAR (PR Newswire)
29.03.22	Bausch Health Will Reduce Debt By $200 Million (PR Newswire)
28.03.22	Bausch + Lomb, Clearside Biomedical Launch XIPERE For Macular Edema Associated With Uveitis In U.S. (RTTNews)
28.03.22	Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Asso... (PR Newswire)
24.03.22	New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency... (PR Newswire)
22.03.22	Gary Gemignani Will Join Solta Medical Corporation As Chief Financial Officer (PR Newswire)
22.03.22	Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting (PR Newswire)
03.03.22	Bausch Health Announces Participation in Upcoming Investor Conferences (PR Newswire)
02.03.22	Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program (PR Newswire)
01.03.22	Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings (PR Newswire)
24.02.22	Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference (PR Newswire)
23.02.22	Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance (PR Newswire)
22.02.22	OraPharma Launches OraFit™ Custom Clear Dental Aligner System (PR Newswire)
22.02.22	Ausblick: Bausch Health legt Zahlen zum jüngsten Quartal vor (finanzen.net)
15.02.22	Salix Announces 2022 Gastrointestinal Health Scholars Program (PR Newswire)
08.02.22	Solta Medical Corporation Files Registration Statement for Proposed Initial Public Offering (PR Newswire)
08.02.22	Erste Schätzungen: Bausch Health legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
03.02.22	Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 (PR Newswire)
01.02.22	BAUSCH + LOMB AND PREVENT BLINDNESS LAUNCH ANNUAL AMD AWARENESS MONTH CAMPAIGN TO EDUCATE PATIENTS (PR Newswire)
27.01.22	Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes (PR Newswire)
27.01.22	Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes (PR Newswire)
20.01.22	Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer (PR Newswire)
18.01.22	Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation (PR Newswire)
13.01.22	Bausch + Lomb Corporation Files Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering (PR Newswire)
11.01.22	Bausch Health Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference (PR Newswire)
06.01.22	3. Quartal 2021: Die Investitionen von Carl Icahn aus dem vergangenen Jahresviertel (finanzen.ch) Grossinvestor Carl Icahn hat zum Ende des dritten Quartals 2021 wieder seine Beteiligungen offengelegt. Neben ein paar neuen Depots hat Icahn auch den Bestand seiner Top-Holding noch einmal erweitert.» mehr
05.01.22	BAUSCH HEALTH TO PARTICIPATE AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
04.01.22	NEW SURVEY FROM BAUSCH + LOMB AND GLAUCOMA RESEARCH FOUNDATION REVEALS EMOTIONAL AND SOCIAL IMPACT OF HYPEREMIA ON GLAUCOMA PATIENTS (PR Newswire)
22.12.21	RELISTOR® (METHYLNALTREXONE BROMIDE) DATA IS PUBLISHED IN THE JOURNAL OF EMERGENCY MEDICINE (PR Newswire)
06.12.21	APMA Grants Seal of Approval for JUBLIA® (efinaconazole) Topical Solution, 10% (PR Newswire)
03.12.21	Salix Brings Educational Resources on Constipation Into the Homes of Patients and Caregivers for Constipation Awareness Month (PR Newswire)
15.11.21	Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs (PR Newswire)
11.11.21	Salix Will Share New Rifaximin Data At AASLD's The Liver Meeting™ 2021 (PR Newswire)
04.11.21	Bausch Health Announces Participation In Upcoming Investor Conferences (PR Newswire)
02.11.21	Bausch Health Q3 Profit Climbs (RTTNews)
02.11.21	Bausch Health Companies Inc. Announces Third-Quarter 2021 Results (PR Newswire)
01.11.21	Bausch + Lomb Will Present Scientific Data and Analyses During the American Academy of Ophthalmology and American Academy of Optometry Annual Meetings (PR Newswire)
27.10.21	Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration With TerraCycle in the United States (PR Newswire)
25.10.21	New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States (PR Newswire)
25.10.21	Salix Will Feature New Data At The American College Of Gastroenterology® 2021 Annual Scientific Meeting (PR Newswire)
25.10.21	Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uv... (PR Newswire)
21.10.21	Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief Financial Officer (PR Newswire)
19.10.21	Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Bausch Health

Aktien Top/Flop

Meistgelesene Nachrichten